{
  "functional_evidence_assessment": [
    {
      "Gene": "EGFR",
      "Protein_Change": {
        "ref": "L",
        "alt": "R",
        "position": "858"
      },
      "variant_string_id": "EGFR L858R",
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the role of mutations in Leucine-rich repeat kinase 2 (LRRK2) in autosomal dominant familial Parkinson's disease. The I2020T mutant specifically is associated with reduced susceptibility to post-translational degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the neurodegenerative mechanism involving mutations in LRRK2 as a factor contributing to the progression of Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses proteolysis inhibitors and observes changes in protein degradation over time.",
          "judgment": "Yes",
          "reasoning": "The methodology, including proteolysis inhibitors and observation of degradation, aligns with assays commonly used to assess neurodegenerative mechanisms."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes multiple replicates (performed in triplicates) and identifies known loss-of-function mutants.",
          "judgment": "Yes",
          "reasoning": "The experimental design uses replicates and identifies relevant controls, supporting the use of these methods."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The evidence suggests that the I2020T mutant LRRK2 variant is pathogenic, as the study identifies reduced susceptibility to post-translational degradation and employs robust experimental designs."
    }
  ]
}